Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatosis Type 1

Explore clinical trials studying Neurofibromatosis Type 1. Study availability and eligibility vary by location and protocol.

59 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Neurofibromatosis Type 1 trial results

Completed

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors

NCT00304083

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +22 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Children's Memorial Hospital - Chicago Chicago, Illinois, United States
  • Indiana University Indianapolis, Indiana, United States
View all 17 locations
View Trial Details
Completed

A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1

NCT00853580

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

NCT00634270

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • National Cancer Institute (NCI) Bethesda, Maryland, United States
View Trial Details

Related conditions